Robeco Institutional Asset Management B.V. Eagle Pharmaceuticals, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$41.26 - $51.35 $178,614 - $222,294	-4,329 Closed	0 $0
Q1 2021 Dec 01, 2022	BUY	$40.32 - $50.97 $174,545 - $220,649	4,329 New	4,329 $180,000
Q4 2020 Dec 01, 2022	BUY	$41.72 - $51.34 $180,605 - $222,250	4,329 New	4,329 $202,000
Q4 2019 Feb 06, 2020	SELL	$54.32 - $64.31 $151,607 - $179,489	-2,791 Reduced 39.2%	4,329 $260,000
Q3 2019 Oct 17, 2019	BUY	$53.25 - $59.98 $259,327 - $292,102	4,870 Added 216.44%	7,120 $403,000
Q3 2018 Oct 31, 2018	BUY	$66.65 - $83.86 $149,962 - $188,685	2,250 New	2,250 $156,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account